文献速递主动脉疾病

急性复杂性B型主动脉夹层的胸主动脉腔内修复术

Thoracic endovascular repair for acute complicated type B aortic dissections.
PubMed 文献 · J Vasc Surg · 2019-01-01

本研究回顾性评估了55例因危及生命的急性复杂性B型主动脉夹层接受急诊胸主动脉腔内修复术(TEVAR)患者的院内死亡率和长期结果。技术成功率为91%,院内死亡率为9%,早期死亡率在组A(灌注不良、濒临破裂或破裂)与组B(持续性疼痛、主动脉直径快速增大或真假腔比例显著变化)间有统计学差异(7% vs 2%;P < .02)。1年、2年和5年实际生存率分别为87%、85%和75%,免于主动脉相关死亡分别为87%、87%和77%。结论认为TEVAR对该高危人群是优异的治疗方式,中期和长期结果良好。

要点

  • 急诊TEVAR治疗急性复杂性B型主动脉夹层技术成功率达91%,院内死亡率为9%。
  • 组A(灌注不良、濒临破裂或破裂)早期死亡率显著高于组B(7% vs 2%;P < .02)。
  • 1年、2年和5年实际生存率分别为87%、85%和75%。

核心结论

  • 在该高危患者队列中,TEVAR被证明是急性复杂性B型主动脉夹层的优异治疗方式,中期和长期结果良好。

研究设计与样本

  • 患者根据临床表现分为两组:组A为灌注不良、濒临破裂或破裂;组B为持续性疼痛、主动脉直径快速增大或真假腔比例显著变化。
  • 4例(7%)既往有主动脉手术史。

主要发现

  • 技术成功(覆盖主要内膜破口)在50例(91%)患者中实现。
  • 总体院内死亡率为9%(n = 5),组A与组B早期死亡率有统计学差异(7% vs 2%;P < .02)。
  • 院内死亡原因均为主动脉相关,包括术中及术后第一天破裂各1例,以及TEVAR后红夹层(升主动脉2例,降主动脉1例)导致主动脉破裂3例。
  • 永久性神经功能障碍发生于5例患者(卒中2例;截瘫3例)。
  • 总体19例(34%)发生早期内漏(IA型5例;IB型11例;II型2例;IB型加II型1例);5例需早期(30天内)血管内干预,其余14例保守治疗并CT血管造影随访;7例早期内漏患者在随访期间(平均术后间隔92 ± 56个月)因主动脉进展需血管内干预(n = 3)或传统手术(n = 4)。

临床怎么用

  • 对于急性复杂性B型主动脉夹层的高危患者,急诊TEVAR可作为有效的治疗选择。
  • 术后需密切监测内漏及主动脉进展,部分患者可能需要早期或远期再干预。

局限性

  • 本研究为回顾性设计,样本量有限(55例),结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study retrospectively assessed in-hospital mortality and long-term results of emergency thoracic endovascular aortic repair (TEVAR) for patients with life-threatening acute complicated type B aortic dissection (acTBD). METHODS: Between March 2001 and December 2016, there were 55 patients (40 male; median age, 52 ± 13 years) with an acTBD who were treated with TEVAR for malperfusion (58%), aortic rupture (18%), or persistent untreatable pain with true lumen reduction or rapid aortic diameter enlargement (24%) as a sign of disease progression. The patients were categorized according to clinical appearance into two groups: group A, malperfusion, pending rupture, or rupture; and group B, persistent ongoing pain, rapid enlargement of aortic diameter, or significant changes in the true to false lumen ratio. Four patients (7%) had undergone previous aortic surgery. RESULTS: Technical success (coverage of the primary intimal tear) was achieved in 50 patients (91%). The overall in-hospital mortality rate was 9% (n = 5), and there was a statistically significant difference in early mortality between group A and group B (7% vs 2%; P < .02). Causes of in-hospital death were all aorta related, including a rupture during the procedure and on the first postinterventional day in two patients and redissection (ascending aorta, n = 2; descending aorta, n = 1) with a consequent aortic rupture after TEVAR in the remaining three. Permanent neurologic dysfunction occurred in five patients (stroke, n = 2; paraplegia, n = 3). Overall, 19 patients (34%) developed early endoleaks (type IA, n = 5; type IB, n = 11; type II, n = 2; type IB plus type II, n = 1). Therefore, 5 patients needed early (within 30 days) endovascular intervention because of a type IA (n = 2), type IB (n = 3), or type II endoleak (n = 1) and the rapid progression of aortic diameter, persistent signs of ischemia (n = 2), or rupture (n = 1), whereas the remaining 14 patients were treated conservatively and followed up by computed tomography angiography. Seven patients with early endoleaks needed an endovascular intervention (n = 3) or conventional surgery (n = 4) because of aortic progression in the follow-up period (mean interval after procedure, 92 ± 56 months). The actual survival rates were 87%, 85%, and 75% at 1 year, 2 years, and 5 years, respectively, and freedom from aorta-related death was 87%, 87%, and 77% at 1 year, 2 years, and 5 years, respectively. Freedom from reintervention for any cause using a Kaplan-Meier analysis was 70%, 68%, 68%, and 63% at 6 months, 1 year, 2 years, and 5 years, respectively. CONCLUSIONS: TEVAR of acTBD has been proven to be an excellent treatment modality in this cohort of high-risk patients, with promising midterm and long-term results.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Stelzmueller ME, Nolz R, Mahr S, et al. Thoracic endovascular repair for acute complicated type B aortic dissections. J Vasc Surg. 2019. PMID: 30683192. doi:10.1016/j.jvs.2018.05.234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。